WallStreetZenWallStreetZen

NYSE: VTR
Ventas Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for VTR

Based on 11 analysts offering 12 month price targets for Ventas Inc

Min Forecast
$73.00-6.24%
Avg Forecast
$80.27+3.1%
Max Forecast
$88.00+13.02%

Should I buy or sell VTR stock?

Based on 11 analysts offering ratings for Ventas Inc.

Strong Buy
Strong Buy
6 analysts 54.55%
Buy
2 analysts 18.18%
Hold
3 analysts 27.27%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VTR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates VTR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their VTR stock forecasts and price targets.

VTR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-04
lockedlocked$00.00+00.00%2025-11-25
lockedlocked$00.00+00.00%2025-11-13
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-10-31Find Out Why
UBS
Bottom 15%
15
HoldInitiates Coverage On$73.00-6.24%2025-09-19
Evercore ISI Group
Bottom 6%
6
BuyMaintains$80.00+2.75%2025-09-15
JP Morgan
Bottom 4%
4
Strong BuyMaintains$76.00-2.39%2025-08-26
Argus Research
Bottom 11%
11
Strong BuyReiterates$75.00-3.67%2025-08-26
Raymond James
Top 22%
79
BuyReiterates$78.00+0.18%2025-08-22

1 of 2

Forecast return on equity

Is VTR forecast to generate an efficient return?

Company
5.22%
Industry
6.38%
Market
227.91%
VTR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VTR forecast to generate an efficient return on assets?

Company
2.4%
Industry
3.71%
VTR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VTR earnings per share forecast

What is VTR's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$0.50-10.5%
Avg 2 year Forecast
$0.68+21.52%
Avg 3 year Forecast
$0.99+77.05%
VTR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

VTR revenue forecast

What is VTR's revenue in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$5.7B+3.28%
Avg 2 year Forecast
$6.3B+13.68%
Avg 3 year Forecast
$6.9B+24.93%
VTR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VTR earnings growth forecast

How is VTR forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
19.9%
Industry
20.74%
Market
42.6%
VTR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
VTR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
VTR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

VTR revenue growth forecast

How is VTR forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
7.64%
Industry
9.74%
Market
25.61%
VTR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VTR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VTR vs Healthcare Facility REIT Stocks

TickerPricePrice TargetUp/downsideConsensus
VTR$77.86$80.27+3.10%Strong Buy
OHI$43.97$46.63+6.04%Buy
DOC$16.62$19.57+17.76%Buy
AHR$47.25$53.44+13.11%Strong Buy
CTRE$36.29$39.50+8.85%Strong Buy
View Top Healthcare Facility REIT Stocks

Ventas Stock Forecast FAQ

Is Ventas Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NYSE: VTR) stock is to Strong Buy VTR stock.

Out of 11 analysts, 6 (54.55%) are recommending VTR as a Strong Buy, 2 (18.18%) are recommending VTR as a Buy, 3 (27.27%) are recommending VTR as a Hold, 0 (0%) are recommending VTR as a Sell, and 0 (0%) are recommending VTR as a Strong Sell.

If you're new to stock investing, here's how to buy Ventas stock.

What is VTR's earnings growth forecast for 2025-2027?

(NYSE: VTR) Ventas's forecast annual earnings growth rate of 19.9% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast earnings growth rate of 20.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.6%.

Ventas's earnings in 2025 is $238,014,000.On average, 10 Wall Street analysts forecast VTR's earnings for 2025 to be $235,430,091, with the lowest VTR earnings forecast at $161,118,359, and the highest VTR earnings forecast at $320,592,652. On average, 10 Wall Street analysts forecast VTR's earnings for 2026 to be $319,653,187, with the lowest VTR earnings forecast at $257,789,374, and the highest VTR earnings forecast at $424,168,740.

In 2027, VTR is forecast to generate $465,740,095 in earnings, with the lowest earnings forecast at $382,080,679 and the highest earnings forecast at $542,541,412.

What is VTR's revenue growth forecast for 2025-2027?

(NYSE: VTR) Ventas's forecast annual revenue growth rate of 7.64% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 9.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.61%.

Ventas's revenue in 2025 is $5,555,020,000.On average, 18 Wall Street analysts forecast VTR's revenue for 2025 to be $2,694,857,211,288, with the lowest VTR revenue forecast at $2,428,988,432,904, and the highest VTR revenue forecast at $2,843,292,783,672. On average, 18 Wall Street analysts forecast VTR's revenue for 2026 to be $2,966,362,783,560, with the lowest VTR revenue forecast at $2,485,356,371,784, and the highest VTR revenue forecast at $3,425,291,752,608.

In 2027, VTR is forecast to generate $3,259,945,798,560 in revenue, with the lowest revenue forecast at $2,971,529,844,624 and the highest revenue forecast at $3,876,704,996,472.

What is VTR's forecast return on assets (ROA) for 2025-2028?

(NYSE: VTR) forecast ROA is 2.4%, which is lower than the forecast US REIT - Healthcare Facilities industry average of 3.71%.

What is VTR's Price Target?

According to 11 Wall Street analysts that have issued a 1 year VTR price target, the average VTR price target is $80.27, with the highest VTR stock price forecast at $88.00 and the lowest VTR stock price forecast at $73.00.

On average, Wall Street analysts predict that Ventas's share price could reach $80.27 by Dec 4, 2026. The average Ventas stock price prediction forecasts a potential upside of 3.1% from the current VTR share price of $77.86.

What is VTR's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: VTR) Ventas's current Earnings Per Share (EPS) is $0.56. On average, analysts forecast that VTR's EPS will be $0.50 for 2025, with the lowest EPS forecast at $0.34, and the highest EPS forecast at $0.68. On average, analysts forecast that VTR's EPS will be $0.68 for 2026, with the lowest EPS forecast at $0.55, and the highest EPS forecast at $0.90. In 2027, VTR's EPS is forecast to hit $0.99 (min: $0.81, max: $1.16).

What is VTR's forecast return on equity (ROE) for 2025-2028?

(NYSE: VTR) forecast ROE is 5.22%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.